NSW health body tweaks cannabis prescribing conditions ‘to reduce regulatory barriers’ by Steve Jones August 1, 2024August 1, 2024 Health regulators in New South Wales have eased conditions imposed on prescribers of schedule 8 medicinal […]
US cannabis giant takes aim at local firm amid legal stoush over Cookies branding by Steve Jones August 1, 2024October 24, 2024
Hope for patients as legal defence edges closer for unimpaired drivers who test positive for THC by Steve Jones July 31, 2024August 5, 2024
Cann Group considers capital raise and Mildura sale and leaseback as financial juggling act goes on by Steve Jones July 31, 2024July 31, 2024
Althea suffers rocky end of year but posts bullish FY25 guidance by Steve Jones July 31, 2024July 31, 2024
‘Unity is crucial’: MCIA and ETAA to merge in move to present united front in Canberra by Steve Jones July 29, 2024August 1, 2024
Full year revenue jumps 29% but ‘price pressure’ dents fourth quarter for ECS Botanics by Steve Jones July 29, 2024July 29, 2024
RACGP bans medicinal cannabis firms from exhibiting at national conference by Steve Jones July 25, 2024July 25, 2024
We need honesty and integrity, not hyperbole and mistruths, if home-grown cannabis is to thrive by Tim Oates July 25, 2024July 25, 2024
Cann Group outlines ‘investment opportunity’ with four-year growth plan and Mildura expansion by Steve Jones July 25, 2024July 25, 2024
